5-(Piperidin-1-yl)thiophene-2-carbaldehyde

Catalog No. :
ACXJTL824
CAS No. :
24372-48-3
Molecular Formula :
C10H13NOS
Molecular Weight :
195.29

IUPAC Name:5-(piperidin-1-yl)thiophene-2-carbaldehyde

5-(Piperidin-1-yl)thiophene-2-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$69.00Login to see priceIn stockInquiry
5g98%$213.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Piperidin-1-yl)thiophene-2-carbaldehyde
IUPAC Name5-(piperidin-1-yl)thiophene-2-carbaldehyde
MDL No.0
Molecular FormulaC10H13NOS
Molecular Weight195.29
SMILESO=CC1=CC=C(N2CCCCC2)S1
InChI KeySFDXRMCPPLZJBG-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB010938;5-PIPERIDINO-2-THIOPHENECARBALDEHYDE;5-PIPERIDIN-1-YL-THIOPHENE-2-CARBALDEHYDE;AKOS BBS-00002922;IFLAB-BB F1935-0010;ASINEX-REAG BAS 02645912;5-PIPERIDINOTHIOPHENE-2-CARBALDEHYDE;5-(Piperidin-1-yl)thiophene-2-carboxaldehyde
CAS No.24372-48-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXJTL824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLBYH590 route compound structure diagram
    ACLBYH5904701-17-1 In Stock
  4. Then
  5. ACXJTL824 route product structure diagram
    ACXJTL82424372-48-3 In Stock
Inquiry

2. ACXJTL824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXUTD801 route compound structure diagram
    ACXUTD80119983-20-1 In Stock
  4. Then
  5. ACXJTL824 route product structure diagram
    ACXJTL82424372-48-3 In Stock
Inquiry

Comments (0)